Titan America SA Common Shares (TTAM)
14.81
-0.74 (-4.76%)

Via Benzinga · March 4, 2025

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025